Loading...
XASX
CCO
Market cap3mUSD
Jul 10, Last price  
0.00AUD
1D
50.00%
1Q
0.00%
IPO
-25.00%
Name

Calmer Co International Ltd

Chart & Performance

D1W1MN
XASX:CCO chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
95.43%
Rev. gr., 5y
60.31%
Revenues
8m
+88.48%
0003,960149,112758,8671,160,1662,050,7381,784,2434,262,8408,034,682
Net income
-4m
L+7.13%
-3,060-4,366-101,964-386,253-4,666,035-3,766,407-3,390,522-5,916,235-5,241,884-3,726,655-3,992,277
CFO
-4m
L+110.49%
-1,131-2,1160-162,935-2,209,569-3,538,830-4,140,332-6,135,580-3,802,225-2,076,285-4,370,391

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fiji Kava Limited operates as a health and wellness enterprise specializing in medicinal kava products, conducting its business across Australia, New Zealand, Fiji, and the United States. The company manufactures and distributes various noble kava extract products, including capsules and powder mixes, marketed under its Fiji Kava and Taki Mai labels. Customers can also acquire their products through the official website, fijikava.com. Established in 2014, Fiji Kava Limited has its main office located in West End, Australia.
IPO date
Dec 20, 2018
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT